Vor Biopharma Inc.

NASDAQ: VOR · Real-Time Price · USD
2.13
0.15 (7.58%)
At close: Aug 15, 2025, 3:59 PM
2.12
-0.24%
After-hours: Aug 15, 2025, 07:58 PM EDT

Vor Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-116.91M -117.86M -92.09M -68.9M
Depreciation & Amortization
3.53M 3.49M 2.52M 1.43M
Stock-Based Compensation
9.85M 13.36M 10.7M 4.32M
Other Working Capital
-2.24M -2.2M -12.69M -9.59M
Other Non-Cash Items
3.87M 67K 6.42M 3.19M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
5K 650K -12.69M -9.19M
Operating Cash Flow
-99.66M -100.29M -85.14M -69.14M
Capital Expenditures
-229K -1.07M -8.46M -3.89M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-9.91M -74.92M -123.19M -87.76M
Sales Maturities Of Investments
107M 147M 37.56M n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
96.86M 71.01M -94.09M -91.65M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-2.43M -1.64M 1.17M -1.66M
Financial Cash Flow
53.39M 2.94M 117.14M 232.91M
Net Cash Flow
50.59M -26.35M -62.09M 72.12M
Free Cash Flow
-99.89M -101.36M -93.61M -73.04M